(Health Korea News / Park Won-jin) The Korea Health Management Association (KHA) will introduce Daewoong Pharmaceutical’s wearable electrocardiogram patch ‘Mobicare’ to health promotion clinics in 17 cities and provinces across the country to increase the early diagnosis rate of arrhythmia through health checkups.
This test involves attaching a wearable electrocardiogram patch to the chest to continuously monitor electrocardiogram data. Depending on the time of the test, it is divided into a same-day electrocardiogram and a one-day electrocardiogram.
Same-day ECG is a test that checks continuous ECG data by attaching a patch while receiving a health checkup, and 1-day ECG is a test that monitors ECG data for a day after returning home with a patch attached after a health checkup. The 1-day ECG device provides a courier pickup service for customer convenience.
Arrhythmia is a disease in which the heartbeat deviates from the normal range, and continuous electrocardiography tests can continuously monitor electrocardiogram data in daily life, making them useful for early diagnosis of arrhythmia.
Kim In-won, chairman of the Korea Heart Association, said, “As the elderly population increases and eating habits become westernized, the number of patients with arrhythmia is also increasing,” and added, “By performing 12-lead electrocardiography and continuous electrocardiography together, we expect to increase the detection rate of arrhythmia disease as well as heart disease, and we expect to improve the efficiency of treatment through early detection.”
Lee Chang-jae, CEO of Daewoong Pharmaceutical, said, “Mobicare is receiving attention as a next-generation electrocardiogram test solution that improves the shortcomings of existing testing devices such as Holter, and enhances accuracy, convenience, and economy.” He added, “Through this Mobicare supply contract, we will popularize AI electrocardiogram test solutions and contribute to the promotion of national health by increasing the efficiency of early diagnosis and treatment of related diseases.”
Meanwhile, on Tuesday, July 16, the Korea Health Promotion Association signed a contract for the introduction of MobiCare at the Health Promotion Clinic of the Korea Health Promotion Association with the attendance of Secretary General Lee Eun-hee, CEO Lee Chang-jae of Daewoong Pharmaceutical, and CEO Lee Young-shin of C-Technology, the developer of MobiCare, at the headquarters of Daewoong Pharmaceutical.
Celebrating its 60th anniversary this year, the Korea Health Insurance Corporation (KHIC) is a health screening institution that operates 17 health promotion centers, including health screenings provided by the National Health Insurance Corporation and comprehensive screenings, as well as customized programs such as cardiovascular screenings for the early detection and prevention of cardiovascular diseases and cardiovascular/cerebrovascular screenings.
Copyright © Health Korea News. Unauthorized reproduction and redistribution prohibited.
Source: www.hkn24.com
